Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANX-101 in migraine with nausea
NCT03185143Phase 3Completed
- Sponsor
- Allodynic Therapeutics
- Start
- Jun 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naltrexone and acetaminophen in migraine, sponsored by Allodynic Therapeutics. Started Jun 2017; status: completed.
02
Drugs
naltrexoneacetaminophen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03185143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185143.